Bulletin
Investor Alert

London Markets Open in:

Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 7, 2023, 7:56 p.m.

/zigman2/quotes/216213707/composite

$

18.95

Change

+0.03 +0.16%

Volume

Volume 211

Quotes are delayed by 20 min

/zigman2/quotes/216213707/composite

Previous close

$ 20.08

$ 18.92

Change

-1.16 -5.78%

Day low

Day high

$18.12

$20.07

Open

52 week low

52 week high

$8.39

$23.91

Open

Maria-Luisa Maccecchini

Maria-Luisa Maccecchini founded Annovis Bio, Inc., Message Pharmaceuticals, Inc. and Annovis, Inc. Currently, Dr. Maccecchini occupies the position of President, Chief Executive Officer & Director at Annovis Bio, Inc. Dr. Maccecchini is also on the board of Treventis Corp., Lantern Pharma, Inc. and Translational Development Acquisition Corp.

She previously was Chief Executive Officer for Message Pharmaceuticals, Inc., General Manager at Bachem Bioscience, Inc., Member of Robin Hood Ventures, Chief Executive Officer at Annovis, Inc., Head-Molecular Biology at Mallinckrodt, Inc.(Old), Director & Partner at Mid-Atlantic Angel Group and Head-Molecular Biology at Mallinckrodt LLC.

Maria-Luisa Maccecchini received a doctorate from The Rockefeller University.

Transactions

Date Shares Transaction Value
01/14/2022 32,959   Derivative/Non-derivative trans. at $0.14 per share. 4,614
12/20/2021 20,000   Gift at $0 per share. 0
10/11/2021 18,000   Acquisition at $27.61 per share. 496,980
07/01/2021 1,000   Gift at $0 per share. 0
07/01/2021 1,000   Gift at $0 per share. 0
07/15/2020 10,000   Gift at $0 per share. 0
04/27/2020 10,000   Gift at $0 per share. 0
01/31/2020 762,896   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 7,937   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 1,600   Acquisition at $6 per share. 9,600

Officers and Executives

Dr. Maria-Luisa Maccecchini
President, Chief Executive Officer & Director
Mr. Henry Hagopian
Dr. Cheng Fang
Senior Vice President-Research & Development
Ms. Eve M. Damiano
Senior Vice President-Regulatory Operations
Mr. Michael B. Hoffman
Chairman
Mr. Reid S. McCarthy
Independent Director
Dr. Claudine E. Bruck
Independent Director
Mr. Mark White
Independent Director
Link to MarketWatch's Slice.